跳至主要内容
临床试验/NCT07645391
NCT07645391招募中不适用

Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer

University of Michigan Rogel Cancer Center1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
1

研究概览

简要总结

This study evaluates urinary biomarkers and PSA to help determine the best approach to early detection of prostate cancer in patients with an elevated familial risk.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
35 Years 至 70 Years(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • * Age 35-70 years
  • Capable of providing informed consent
  • Prognosis of > 5 years if affected by another cancer
  • Patients need one to meet at least one of the following high genetic risk categories:
  • Known PCa-related mutations: BRCA 1 and 2, Lynch syndrome, or p53
  • Carrier of mutation in a suspected PCa-related gene: e.g., ATM, PALB2, CHEK2, RAD51D, ATR, NBN, GEN1, RAD51C, MRE11A, BRIP1, FAM175A, HOXB13
  • Obligate carriers of the above mutations (e.g. their sisters/daughters have known mutations)
  • Men with any family history of above mutation
  • Family history of breast, prostate, or ovarian cancer in at least 2 individuals, or in 1 individual diagnosed before age 50

排除标准

  • * Anuria
  • Prior diagnosis or treatment for PCa
  • Failure to provide informed consent
  • Life expectancy < 5 years

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验